An investigation for investors in Venaxis Inc (NASDAQ:APPY) shares over potential securities laws violations by Venaxis was announced and NASDAQ:APPY stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 02/03/2015 --An investigation on behalf of investors of Venaxis Inc (NASDAQ:APPY) shares over potential securities laws violations by Venaxis and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of Venaxis Inc (NASDAQ:APPY) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Venaxis Inc (NASDAQ:APPY) concerning whether a series of statements by Venaxis Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Venaxis Inc reported that its annual Net Loss increased from $9.21 million in 2012 to $12.15 million in 2013. Shares of Venaxis Inc (NASDAQ:APPY) traded in early 2014 as high as $3.19 per share.

On January 29, 2015, Venaxis Inc announced that, "the United States Food and Drug Administration ("FDA") has determined that the APPY1 Test does not meet the criteria for substantial equivalence based upon data and information submitted by Venaxis in its 510(k) submission." Its appendicitis test was not found to be substantially equivalent to standard of care by the U.S. health regulator. Shares of Venaxis Inc (NASDAQ:APPY) declined from $2.09 per share on January 28, 2015 to as low as $0.52 per share on January 29, 2015.

On January 30, 2015, NASDAQ:APPY shares closed at $0.50 per share.

Those who purchased shares of Venaxis Inc (NASDAQ:APPY) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com